Ekkio Capital invests in FX Solutions

A source close to the deal confirmed that the GP acquired a majority stake.

Ekkio IV was the vehicle used for for the transaction. This is the fund's first investment. A spokesperson for Ekkio confirmed that the vehicle held a first close on €135m in December 2017 and its hard-cap is set at €150m. 

The family of the founder, Jean-Jacques Martin, as well as the management team remained investors in the company.  

Kreaxi, Rhône Dauphiné Développement and Esfin Participations exited the investment as a result of Ekkio's investment. 

CM-CIC Private Debt provided unitranche debt to finance the deal. 

The GP's funding will help FX Solution's expansion in the US.

Company
Founded in 2011, FX Solutions develops implants, instruments, and surgical techniques for orthopedic surgeons performing shoulder arthroplasty. The company generated a turnover of €11m in 2017. FX Solutions is headquartered in Viriat.

People
Ekkio Capital – Jean-Marc Sceo (president); Alexandre Colcombet (director). 
FX Solutions – Jean-Jacques Martin (CEO).
Esfin Participations – Philippe Céas (CEO).
Kreaxi – Isabelle Bou Antoun (partner). 
Rhône Dauphiné Développement – Pierre Jourdain (director).

Advisers
Equity – Potomac Capital Conseil, Sébastien Drouot, Ahmed Soibah-Eddine (M&A); LEK Consulting, Arnaud Sergent, André Isak, Jean-Guillaume Bayada, Maxime Julian (commercial due diligence); Dechert, Anne-Charlotte Rivière-Wilson, Pierre-Henri Brieau, Alexia Delahousse, Sophie Pelé, Jessica Garestier, Antoine Le Touzé (legal); Deloitte, Thomas Fischer, Steven Berard, Benjamin Deloffre (financial due diligence).
Company – UBS M&A Mid-Cap, Jérôme Breuneval, Julien Lafarge, Maxime Moreira (M&A); LexCase, Guillaume Pierson, Pénélope Bouchard, Simon Wesley (legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• France
• Healthcare
• Exits
• France
• Ekkio Capital
• Secondary buyout